Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-17

Clinical Trial Update: Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) [Phase 4]

View source ↗

Summary

A Phase 4 Pfizer trial in adults with major depressive disorder compares discontinuation symptoms after stopping the DVS SR formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DVS SR

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-02-17